source
- UniQure, in ‘symbolic’ win, to seek UK approval of Huntington’s gene therapyNews of the submission, which would be the first for UniQure’s closely watched treatment, comes as the therapy faces an uncertain future in the U.S.BioPharma Dive · 3mo ago↗ source
- STAT+: FDA wants to exclude weight loss drugs from a compounding listFDA moves to remove semaglutide, tirzepatide, and liraglutide from its 503B compounding list, saying there's no shortage of GLP-1 drugs from Novo Nordisk and Eli Lilly.STAT · 3mo ago↗ source
- STAT+: Five-way obesity drug is super effective — in miceA 'quintuple agonist,' Alector halts it Alzheimer's trial, and more biotech news from The ReadoutSTAT · 3mo ago↗ source